Abstract |
Blood coagulation, immunobiochemical, and clinical characteristics were studied in patients with rheumatic fever running a protracted course treated by combined therapy including nerobol. To assess the therapeutic efficacy of nerobol, the patients were divided into 2 groups: Group 1 (30 patients) were administered combined antirheumatic therapy, Group 2 (30 patients) were administered the same + nerobol in a daily dose of 15 mg for 3-4 weeks. The findings evidence a positive effect of the drug on the status of patients in whom rheumatic fever runs a protracted course: blood procoagulative activity is reduced and anticoagulative activity elevated, blood immunobiochemical and clinical characteristics normalized.
|
Authors | V A Likhatskaia, A V Epishin, P A Furtel' |
Journal | Laboratornoe delo
(Lab Delo)
Issue 8
Pg. 42-4
( 1991)
ISSN: 0023-6748 [Print] Russia (Federation) |
Vernacular Title | Sostoianie gemokoaguliatsii, immunobiokhimicheskie i klinicheskie pokazateli u bol'nykh aktivnym revmatizmom pri lechenii nerobolom. |
PMID | 1724507
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
|
Topics |
- Adolescent
- Adult
- Blood Coagulation
(drug effects)
- Female
- Humans
- Male
- Methandrostenolone
(therapeutic use)
- Middle Aged
- Rheumatic Diseases
(blood, drug therapy, immunology)
|